The judge overseeing a class action against American Medical Systems over allegedly defective pelvic mesh implants has rejected the medical device maker’s bid to alter the start date for a sub-group of class members.
The Australian Competition and Consumer Commission has successfully escaped a lawsuit by a Chinese vitamin company Nature’s Care after arguing it had been wrongly “dragged” into the case.
Public hospital operators in NSW have been hit with a class action over a practice of forcing non-resident patients ineligible for Medicare cards to find Australian citizens to be guarantors before they are treated.
Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.
Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that’s backing the case.
Cash Converters has reached a settlement on the eve of trial in one of two consumer class actions alleging it engaged in unconscionable conduct by imposing high interest rates on short-term loans.
Domino’s Pizza and Precision Tracking have reached a settlement on the eve of trial in a hard-fought battle by the US pizza giant to invalidate two of the Australian tech startup’s patents covering a GPS system that helps customers locate delivery drivers in real-time.
The New South Wales transportation regulator in charge of the Sydney light rail project says contractor Acciona Infrastructure is delaying a lawsuit over $1.2 billion in fees for the project by repeatedly ignoring requests for pleadings.
A Federal Court judge on Friday called a request for particulars by Qantas “ridiculous”, during the first hearing in a case brought by mechanics alleging they weren’t pay allowances owed while working on assignment in Los Angeles.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.